Finadyne 50 ML

Presentation

Solution for injection 

Active ingredients

Each ml contains:

Active substance:

50 mg Flunixin equivalent to 83 mg Flunixin meglumine.

Target species

Cattle, horses and pigs

Indications for use

In Cattle:
Adjunctive therapy in the treatment of bovine respiratory diseases, endotoxemia and acute mastitis.
Alleviation of acute inflammation and pain associated with musculoskeletal disorders.   
Reduction of post-operative pain associated with dehorning in calves of less than 9 weeks. 

In Horses:

Alleviation of acute inflammation and pain associated with musculoskeletal disorders.

Alleviation of visceral pain associated with colic.

Adjunctive therapy of endotoxemia due to or as a result of post-surgical or medical conditions or diseases that result in impaired blood circulation in the gastrointestinal tract.

Reduction of pyrexia

In Pigs:
Adjunctive therapy in the treatment of swine respiratory disease.
Adjunctive treatment of postpartum dysgalactia (Mastitis-Metritis-Agalactia) syndrome in sows.
Alleviation of acute inflammation and pain associated with musculoskeletal disorders.
Reduction of post-operative pain following castration and tail docking in sucking piglets. 

Withdrawal periods

Animals must not be slaughtered for human consumption during treatment. 
Cattle: 

Meat and offal:                4 days (intravenous use)
                                        31 days (intramuscular use)
Milk:                                 24 hours (intravenous use)
                                        36 hours (intramuscular use)

Pigs:

Meat and offal:                24 days (intramuscular)

Horses:

Meat and offal:                5 days (intravenous use)
Milk:                                Not authorised for use in animals producing milk for human consumption

Milk for human consumption must not be taken during treatment.